Opposite Change ofIn VivoDopamine Release in the Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation of Dorsal Raphe Nucleus: Role of 5-HT3Receptors
- 15 August 1998
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 18 (16) , 6528-6538
- https://doi.org/10.1523/jneurosci.18-16-06528.1998
Abstract
In the present study we investigate, using in vivomicrodialysis, the involvement of central 5-HT3 receptors in the effect of dorsal raphe nucleus (DRN) electrical stimulation on dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), and 5-hydroxyindole-3-acetic acid (5-HIAA) extracellular levels monitored in the nucleus accumbens and the striatum of halothane-anesthetized rats. DRN stimulation (300 μA, 1 msec at 3, 5, 10, and 20 Hz for 15 min) induced a frequency-dependent increase of accumbal DA release and a concomitant reduction of DA release in the ipsilateral striatum at 20 Hz. In both structures DOPAC and 5-HIAA dialysate contents were enhanced in a frequency-dependent manner. Central serotonin (5-HT) depletion, induced by intra-raphe injections of 5,7-dihydroxytryptamine neurotoxin, abolished the effect of 20 Hz DRN stimulation on DA, DOPAC, and 5-HIAA extracellular levels in both regions. The 5-HT synthesis inhibitor para-chlorophenylalanine (3 × 400 mg/kg, i.p., for 3 d), although preventing the effect on DA release, failed to modify significantly the effect of 20 Hz DRN stimulation on DOPAC and 5-HIAA outflow in both structures. Ondansetron (0.1 and 1 mg/kg) and (S)-zacopride (0.1 mg/kg), two 5-HT3 antagonists, significantly impaired the increase of accumbal DA release induced by 20 Hz DRN stimulation but did not affect either the decrease of striatal DA release or the increase in DOPAC outflow in both structures. These results indicate that an enhancement of central 5-HT transmission induced by DRN stimulation differentially affects striatal and accumbal DA release and that endogenous 5-HT, via its action on 5-HT3 receptors, exerts a facilitatory control restricted to the mesoaccumbal DA pathway.Keywords
This publication has 48 references indexed in Scilit:
- The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric studyPublished by Elsevier ,2003
- The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbensPublished by Elsevier ,2002
- Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studiesPublished by Elsevier ,1999
- 5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic systemBehavioural Brain Research, 1995
- d‐Fenfluramine Increases Striatal Extracellular Dopamine In Vivo Independently of Serotonergic Terminals or Dopamine Uptake SitesJournal of Neurochemistry, 1995
- GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in ratsPharmacology Biochemistry and Behavior, 1991
- The concept of selectivity in 5-HT receptor researchEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- The effect of serotonergic agents on haloperidol-induced catalepsyLife Sciences, 1990
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the ratJournal of Comparative Neurology, 1978